← Back to Search

Behavioural Intervention

Physical Activity & Education for Obesity

N/A
Recruiting
Led By Jacob Kariuki, PhD, NP
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥18 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months after screening procedures start
Awards & highlights

Study Summary

This trial will study how enjoyable, less exhausting activities can help individuals with obesity reduce cardiometabolic risks, regardless of weight loss.

Who is the study for?
This trial is for adults over 18 with obesity (BMI ≥30kg/m2) who don't meet physical activity guidelines and have regular internet access. It's not for pregnant individuals, those in health-related litigation, or people needing supervised exercise due to conditions like stroke or diabetes.Check my eligibility
What is being tested?
The study tests a program called PATH which uses peers similar in body size and fitness to encourage physical activities like walking, dancing, and toning exercises. Participants will also receive dietary education and use a physical activity tracker.See study design
What are the potential side effects?
Since the interventions involve common physical activities and educational components, side effects are minimal but may include typical exercise-related discomforts such as muscle soreness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months after screening procedures start
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months after screening procedures start for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to protocol procedures
Attainment of recruitment goal
Participants' satisfaction of protocol procedures (acceptability)
+1 more
Secondary outcome measures
Changes in Monocyte Chemoattractant Protein-1 (MCP-1)
Changes in T2D risk score
Changes in adiponectin and leptin
+1 more
Other outcome measures
Change in exercise self-efficacy questionnaire (EXSE)
Change in exercise self-regulation
Change in the Outcome Expectations for Exercise Scale questionnaires.
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: PATH InterventionExperimental Treatment3 Interventions
Insufficiently active adults with obesity will be assigned to the PATH intervention.
Group II: Control GroupExperimental Treatment3 Interventions
Insufficiently active adults with obesity will be assigned to the attention control group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PATH Intervention
2021
N/A
~80
Control Group
2012
Completed Phase 2
~2470
Dietary education
2015
N/A
~70

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,361 Previous Clinical Trials
4,314,850 Total Patients Enrolled
447 Trials studying Obesity
588,936 Patients Enrolled for Obesity
Emory UniversityLead Sponsor
1,641 Previous Clinical Trials
2,561,852 Total Patients Enrolled
21 Trials studying Obesity
15,672 Patients Enrolled for Obesity
American Diabetes AssociationOTHER
139 Previous Clinical Trials
99,556 Total Patients Enrolled
24 Trials studying Obesity
1,617 Patients Enrolled for Obesity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients able to register for this research trial at the present time?

"Data from clinicaltrials.gov suggests that this trial is no longer enrolling patients, despite originally being posted on December 1st 2023 and was last updated November 7th 2023. There are 1025 other medical trials with open recruitment criteria at the present moment though."

Answered by AI

What goals would the completion of this experiment bring to fruition?

"This 12-week clinical trial aims to meet recruitment goals. Secondary objectives include analyzing changes in Monocyte Chemoattractant Protein-1 (MCP-1) via dry blood spot kits, calculating the American Diabetes Association's T2D risk score and assessing alterations in proinflammatory cytokines such as tumor necrosis factor Alpha (TNF-α), Interleukin-1 beta (IL1β), and Interleukin-6 (IL6)."

Answered by AI

Who else is applying?

What site did they apply to?
Emory University
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Active You: Walk, Dance, and Tone Your Abs to Reduce Your Risk of Diabetes
Jacob Kariuki 2024. "Active You: Walk, Dance, and Tone Your Abs to Reduce Your Risk of Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06127251.
~33 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top